As of Oct 20
| +0.0666 / +3.60%|
The 1 analysts offering 12-month price forecasts for Achieve Life Sciences Inc have a median target of 9.90, with a high estimate of 9.90 and a low estimate of 9.90. The median estimate represents a +416.54% increase from the last price of 1.92.
The current consensus among 1 polled investment analysts is to Hold stock in Achieve Life Sciences Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.